Video Experimental Relacionado
Updated: Jul 12, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
La industria farmacéutica de la India entra en el escenario mundial
1Bangalore, India.
Cell
|March 14, 2007
Resumen
La India es la India.
Área de la Ciencia:
- Ciencias Farmacéuticas Ciencias Farmacéuticas
- Descubrimiento y Desarrollo de Drogas.
- Política de salud global Política de salud global.
Sus antecedentes:
- El papel establecido de la India como un fabricante líder de medicamentos genéricos.
- Colaboraciones emergentes entre compañías farmacéuticas indias y grandes firmas estadounidenses/europeas.
- El panorama en evolución de la innovación farmacéutica en la India.
Objetivo del estudio:
- Analizar el impacto de las colaboraciones internacionales en las capacidades de descubrimiento de fármacos de la India.
- Examinar el entorno regulatorio que influye en la innovación farmacéutica en la India.
- Comprender la transición de las compañías farmacéuticas indias hacia el desarrollo de nuevos medicamentos.
Principales métodos:
- Revisión de las asociaciones y alianzas recientes de la industria farmacéutica.
- Análisis de los marcos regulatorios para patentes, aprobaciones de medicamentos y ensayos clínicos en la India.
- Estudios de casos de compañías indias involucradas en el descubrimiento de fármacos innovadores.
Principales resultados:
- Las empresas farmacéuticas indias se están asociando cada vez más con gigantes globales.
- Estas colaboraciones están fomentando un cambio hacia el descubrimiento de fármacos innovadores.
- Las actualizaciones regulatorias están en curso, impactando los procesos de patentes, aprobación y ensayo.
Conclusiones:
- Las alianzas internacionales son fundamentales para el avance de la India en el descubrimiento de fármacos innovadores.
- El panorama regulatorio en evolución presenta tanto oportunidades como desafíos.
- La adaptación continua de las regulaciones es crucial para el crecimiento sostenido de la innovación farmacéutica.
Videos de Conceptos Relacionados
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...